The comparison of neuroprotective effects of intrathecal dexmedetomidine and metilprednisolone in spinal cord injury

International Journal of Surgery

Volumn 11, Issue 5, 2013, Pages 414-418

  Celik, Feyzi ^a   Göçmez, Cüneyt ^a   Kamaşak, Kaǧan ^a   Tufek, Adnan ^a   Guzel, Abdulmenap ^a   Tokgoz, Orhan ^a   Firat, Uǧur ^a   Evliyaoǧlu, Osman ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Dexmedetomidine; Methylprednisolone; Spinal cord injury

Indexed keywords

ARYLDIALKYLPHOSPHATASE; DEXMEDETOMIDINE; INTERLEUKIN 6; MALONALDEHYDE; METHYLPREDNISOLONE; NITROUS OXIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE EDEMA; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG EFFECT; EDEMA; FEMALE; HISTOPATHOLOGY; INTRATHECAL CATHETER; LAMINECTOMY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; TISSUE NECROSIS;

ANIMALS; DEXMEDETOMIDINE; DISEASE MODELS, ANIMAL; FEMALE; HEMORRHAGE; HISTOCYTOCHEMISTRY; INJECTIONS, SPINAL; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; SPINAL CORD; SPINAL CORD INJURIES; STATISTICS, NONPARAMETRIC;

EID: 84877602919     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2013.03.008     Document Type: Article

References (39)

1. Hagg T., Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. JNeurotrauma 2006, 23(3-4):264-280.
2. Hughes J.T. The Edwin Smith Surgical Papyrus: an analysis of the first case reports of spinal cord injuries. Paraplegia 1988, 26(2):71-82.
3. Noble L.J., Wrathall J.R. Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp Neurol 1985, 88(1):135-149.
4. Noyes D.H. Electromechanical impactor for producing experimental spinal cord injury in animals. Med Biol Eng Comput 1987, 25(3):335-340.
5. Rivlin A.S., Tator C.H. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 1978, 10(1):38-43.
6. Fiford R.J., Bilston L.E., Waite P., Lu J. Avertebral dislocation model of spinal cord injury in rats. JNeurotrauma 2004, 21(4):451-458.
7. Kwon B.K., Oxland T.R., Tetzlaff W. Animal models used in spinal cord regeneration research. Spine 2002, 27(14):1504-1510.
8. Sie I., Waters R.L. Outcomes following spinal cord injury. Spinal cord medicine 2003, 87-103. Demos, New York. V.W. Lin (Ed.).
9. Kwon B.K., Fisher C.G., Dvorak M.F., Tetzlaff W. Strategies to promote neural repair and regeneration after spinal cord injury. Spine 2005, 30(15):3-13.
10. Hugenholtz H., Cass D.E., Dvorak M.F., Fewer D.H., Fox R.J., Izukawa D.M., et al. High-dose methylprednisolone for acute closed spinal cord injury: only a treatment option. Can J Neurol Sci 2002, 29(3):227-235.
11. Gul S., Hanci V., Bahadir B., Acikgoz S., Bektas S., Ankarali H., et al. The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats. JClin Neurosci 2010, 17(4):490-494.
12. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976, 17(6):1031-1036.
13. Korkmaz H.A., Maltepe F., Erbayraktar S., Yilmaz O., Güray M., Canda M.B., et al. Antinociceptive and neurotoxicologic screening of chronic intrathecal administration of ketorolac tromethamine in the rat. Anesth Analg 2004, 98(1):148-152.
14. Senoglu M., Nacitarhan V., Kurutas E.B., Senoglu N., Altun I., Atli Y., et al. Intraperitoneal alpha-lipoic acid to prevent neural damage after crush injury to the rat sciatic nerve. JBrachial Plexus Peripher Nerve Inj 2009, 4:22-28.
15. Erel O. Anovel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004, 37(2):112-119.
16. Erel O. Anew automated colorimetric method for measuring total oxidant status. Clin Biochem 2005, 38(12):1103-1111.
17. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990, 186:407-421.
18. Eckerson H.W., Romson J., Wyte C., La Du B.N. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1993, 35(2):214-227.
19. Can M., Gul S., Bektas S., Hanci V., Acikgoz S. Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury. Acta Anaesthesiol Scand 2009, 53(8):1068-1072.
20. Chvatal S.A., Kim Y.T., Bratt-Leal A.M., Lee H., Bellamkonda R.V. Spatial distribution and acute anti-inflammatory effects of methylprednisolone after sustained local delivery to the contused spinal cord. Biomaterials 2008, 29(12):1967-1975.
21. Lammertse D.P. Update on pharmaceutical trials in acute spinal cord injury. JSpinal Cord Med 2004, 27(4):319-325.
22. Bracken M.B., Holford T.R. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. JNeurosurg 1993, 79(4):500-507.
23. Coleman W.P., Benzel D., Cahill D.W., Ducker T., Geisler F., Green B., et al. Acritical appraisal of the reporting of the national acute spinal cord injury studies (I and II) of methylprednisolone in acute spinal cord injury. JSpinal Disord 2000, 13(3):185-199.
24. Paris A., Tonner P. Dexmedetomidine in anaesthesia. Curr Opin Anesthesiol 2005, 18(4):412-418.
25. Eser O., Fidan H., Sahin O., Cosar M., Yaman M., Mollaoglu H. The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res 2008, 1218:250-256.
26. Sanders R.D., Sun P., Patel S., Li M., Maze M., Ma D. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand 2010, 54(6):710-716.
27. Karlsson B.R., Löberg E.M., Steen P.A. Dexmedetomidine, a potent alpha 2-agonist, does not affect neuronal damage following severe forebrain ischaemia in the rat. Eur J Anaesthesiol 1995, 12(3):281-285.
28. Cosar M., Eser O., Fidan H., Sahin O., Buyukbas S., Ela Y., et al. The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol 2009, 71(1):54-59.
29. Johansson P., Ehrenstrom F. Presynaptic alpha-adrenoceptor regulation of transmitter release in the conscious rat. Comp Biochem Physiol 1988, 89(1):65-69.
30. Talke P., Bickler P.E. Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology 1996, 85(3):551-557.
31. Al-Mustafa M.M., Abu-Halaweh S.A., Aloweidi A.S., Murshidi M.M., Ammari B.A., Awwad Z.M., et al. Effect of dexmedetomidine added to spinal bupivacaine for urological procedures. Saudi Med J 2009, 30(3):365-370.
32. Aldemir O., Celebi H., Cevik C., Duzgun E. The effects of propofol or halothane on free radical production after tourniquet induced ischaemia-reperfusion injury during knee arthroplasty. Acta Anaesthesiol Scand 2001, 45(10):1221-1225.
33. Topsakal C., Kilic N., Ozveren F., Akdemir I., Kaplan M., Tiftikci M. Effects of prostaglandin E1, melatonin, and oxytetracycline on lipid peroxidation, antioxidant defense system, paraoxonase (PON1) activities, and homocysteine levels in an animal model of spinal cord injury. Spine 2003, 28(15):1643-1652.
34. Taysi S., Uslu C., Akcay F., Sutbeyaz M.Y. Levels of malondialdehyde and nitric oxide in plasma of patients with laryngeal cancer. Surg Today 2003, 33(9):651-654.
35. Tüfek A., Tokgöz O., Aliosmanoglu I., Alabalik U., Evliyaoglu O., Ciftçi T., et al. The protective effects of dexmedetomidine on the liver and remote organs against hepatic ischemia reperfusion injury in rats. Int J Surg 2013, 11(1):96-100.
36. Taysi S., Cikman O., Kaya A., Demircan B., Gumustekin K., Yilmaz A., et al. Increased oxidant stress and decreased antioxidant status in erythrocytes of rats fed with Zn-deficient diet. Biol Trace Elem Res 2008, 123(1-3):161-167.
37. Aslan A., Cemek M., Eser O., Altunbaş K., Buyukokuroglu M.E., Cosar M., et al. Does dexmedetomidine reduce secondary damage after spinal cord injury? An experimental study. Eur Spine J 2009, 8(3):336-344.
38. Pineau I., Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. JComp Neurol 2007, 500(2):267-285.
39. Ji Benxiu, Li Mingwei, Budel Stephane, Pepinsky R.Blake, Walus Lee, Engber Thomas M., et al. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. Eur J Neurosci 2005, 22(3):587-594.